Review

Curcumin nanoformulations for modulating neuroinflammation and oxidative stress in Alzheimer's disease: blood-brain barrier transport, formulation strategies and therapeutic applications.

M. Begum Manickam Rajkumar Prabha Govindaraj N. Prathap P. Sudha Mona Al Hamod Hamoud Alotaibi Deenathayalan Uvarajan

Sep 2026 · InflammoPharmacology · 1 citation · 118 references

Medicine

TL;DR

Collectively, nanocarrier-mediated curcumin delivery represents a promising pharmaceutical strategy to improve brain-specific bioavailability and enable effective multitarget therapeutic intervention in AD.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Open access Sep 2026

Herbal nanoparticles in the treatment of neurodegeneration: from molecular mechanisms to therapeutic translation

This review critically summarizes recent advances in herbal nanoformulations, emphasizing disease-specific molecular targets, BBB-targeting strategies, comparative nanocarrier systems, pharmacokinetic optimization, intracellular trafficking, and translational challenges.

D. Mittal, Pavitra Solanki, G. K. Jain et al. · 3 Biotech · 1 citation

Review Oct 2026

Hyaluronic acid-based CeO₂ nanozymes for brain-targeted Parkinson's disease therapy: Biointerface design, multifunctional neuroprotective regulation and future perspectives: A review.

Parkinson's disease (PD) is a progressive neurodegenerative disorder driven by oxidative imbalance, mitochondrial dysfunction, and persistent neuroinflammation, yet current pharmacological interventions provide symptomatic relief but fail to halt neuronal degeneration largely owing to complex pathological mechanisms an...

Qu-Cheng Huang, Yun-Wei Sun, Yue Duan et al. · International Journal of Bio... · 0 citations

Review Sep 2026

Nose-to-Brain Delivery of Polyherbal Nanoformulations in Neurodegenerative Disorders: Translational Strategies and Challenges

The current knowledge on polyherbal synergy, nanocarrier-based targeting methods, and nose-to-brain delivery strategies to treat neurodegenerative disorders are summarized, highlighting their potential therapeutic applications, underlying mechanisms, translational issues, regulatory factors, and emerging trends such as...

Mahalakshmi Seelam, Varalakshmi Sagili · Drug Delivery Letters · 0 citations

Review Open access Sep 2026

The Role of Curcumin in Neurogenesis and Neuroprotection in Alzheimer’s disease: From Molecular Mechanisms to Clinical Evidence

Alzheimer's disease (AD) is the most common form of senile dementia worldwide and is a progressive and irreversible neurodegenerative disorder, which represents a huge socioeconomic burden on modern healthcare systems. The neuropathology of AD is characterised by a very complex, interconnected cascade of cellular event...

V. S, Sarupruthiya M, Jeevitha D et al. · International Journal Of Rec... · 0 citations

Review Open access Sep 2026

Efficacy of Curcumin in Neurodegenerative Diseases: From Pharmacokinetic Barriers to Advanced Delivery Systems

Background and Objectives: The main neurodegenerative diseases (NDs)—Alzheimer’s disease (AD), Parkinson’s disease (PD), multiple sclerosis (MS), and amyotrophic lateral sclerosis (ALS)—represent a growing global health burden with no available disease-modifying therapies. Curcumin, a polyphenol from Curcuma longa, is...

Alejandra Castelló-Guillen, Marta Garrido-Reig, Jordi Caplliure-Llopis et al. · Pharmaceuticals · 0 citations

Review Sep 2026

Bioinspired Nanomaterials for Parkinson's Disease: Engineering Membrane Interfaces to Overcome the Blood-Brain Barrier and Enable Neuron-Targeted Delivery.

Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the selective loss of dopaminergic neurons in the substantia nigra, which gives rise to characteristic motor and non-motor behavioral impairments. Disease-modifying therapies remain elusive, largely due to the restrictive nature of the blood...

Qu-Cheng Huang, Yuan-Yuan Zuo, Yi-Ning Xie et al. · ACS Biomaterials Science & E... · 0 citations